nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—AKT1—schizophrenia	0.555	0.851	CbGaD
Arsenic trioxide—ABCB1—schizophrenia	0.0969	0.149	CbGaD
Arsenic trioxide—MAPK1—blood plasma—schizophrenia	0.00377	0.0362	CbGeAlD
Arsenic trioxide—MAPK3—blood plasma—schizophrenia	0.00333	0.0321	CbGeAlD
Arsenic trioxide—AKT1—blood plasma—schizophrenia	0.00314	0.0302	CbGeAlD
Arsenic trioxide—CCND1—forebrain—schizophrenia	0.00245	0.0235	CbGeAlD
Arsenic trioxide—CCND1—telencephalon—schizophrenia	0.00225	0.0217	CbGeAlD
Arsenic trioxide—MAPK1—forebrain—schizophrenia	0.00206	0.0198	CbGeAlD
Arsenic trioxide—TXNRD1—forebrain—schizophrenia	0.00192	0.0185	CbGeAlD
Arsenic trioxide—MAPK1—telencephalon—schizophrenia	0.0019	0.0182	CbGeAlD
Arsenic trioxide—CCND1—gonad—schizophrenia	0.00188	0.0181	CbGeAlD
Arsenic trioxide—MAPK3—forebrain—schizophrenia	0.00183	0.0176	CbGeAlD
Arsenic trioxide—TXNRD1—telencephalon—schizophrenia	0.00177	0.017	CbGeAlD
Arsenic trioxide—AKT1—forebrain—schizophrenia	0.00172	0.0166	CbGeAlD
Arsenic trioxide—MAPK3—telencephalon—schizophrenia	0.00168	0.0161	CbGeAlD
Arsenic trioxide—CCND1—blood—schizophrenia	0.00164	0.0157	CbGeAlD
Arsenic trioxide—CCND1—midbrain—schizophrenia	0.00162	0.0156	CbGeAlD
Arsenic trioxide—AKT1—telencephalon—schizophrenia	0.00158	0.0152	CbGeAlD
Arsenic trioxide—MAPK1—gonad—schizophrenia	0.00158	0.0152	CbGeAlD
Arsenic trioxide—JUN—forebrain—schizophrenia	0.0015	0.0144	CbGeAlD
Arsenic trioxide—TXNRD1—gonad—schizophrenia	0.00147	0.0142	CbGeAlD
Arsenic trioxide—CYP3A4—urine—schizophrenia	0.00145	0.0139	CbGeAlD
Arsenic trioxide—CCND1—endocrine gland—schizophrenia	0.00142	0.0137	CbGeAlD
Arsenic trioxide—MAPK3—gonad—schizophrenia	0.0014	0.0135	CbGeAlD
Arsenic trioxide—MAPK1—blood—schizophrenia	0.00138	0.0133	CbGeAlD
Arsenic trioxide—JUN—telencephalon—schizophrenia	0.00138	0.0133	CbGeAlD
Arsenic trioxide—IKBKB—telencephalon—schizophrenia	0.00137	0.0132	CbGeAlD
Arsenic trioxide—CCND1—nervous system—schizophrenia	0.00133	0.0128	CbGeAlD
Arsenic trioxide—AKT1—gonad—schizophrenia	0.00132	0.0127	CbGeAlD
Arsenic trioxide—TXNRD1—blood—schizophrenia	0.00128	0.0124	CbGeAlD
Arsenic trioxide—CCND1—central nervous system—schizophrenia	0.00128	0.0123	CbGeAlD
Arsenic trioxide—TXNRD1—midbrain—schizophrenia	0.00127	0.0122	CbGeAlD
Arsenic trioxide—CCND1—cerebellum—schizophrenia	0.00125	0.012	CbGeAlD
Arsenic trioxide—MAPK3—blood—schizophrenia	0.00122	0.0117	CbGeAlD
Arsenic trioxide—MAPK3—midbrain—schizophrenia	0.00121	0.0116	CbGeAlD
Arsenic trioxide—MAPK1—endocrine gland—schizophrenia	0.0012	0.0115	CbGeAlD
Arsenic trioxide—AKT1—blood—schizophrenia	0.00115	0.0111	CbGeAlD
Arsenic trioxide—JUN—gonad—schizophrenia	0.00115	0.0111	CbGeAlD
Arsenic trioxide—IKBKB—gonad—schizophrenia	0.00115	0.011	CbGeAlD
Arsenic trioxide—AKT1—midbrain—schizophrenia	0.00114	0.0109	CbGeAlD
Arsenic trioxide—MAPK1—nervous system—schizophrenia	0.00112	0.0108	CbGeAlD
Arsenic trioxide—TXNRD1—endocrine gland—schizophrenia	0.00111	0.0107	CbGeAlD
Arsenic trioxide—MAPK1—central nervous system—schizophrenia	0.00108	0.0104	CbGeAlD
Arsenic trioxide—MAPK3—endocrine gland—schizophrenia	0.00106	0.0102	CbGeAlD
Arsenic trioxide—MAPK1—cerebellum—schizophrenia	0.00105	0.0101	CbGeAlD
Arsenic trioxide—TXNRD1—nervous system—schizophrenia	0.00104	0.01	CbGeAlD
Arsenic trioxide—CCND1—brain—schizophrenia	0.00102	0.00977	CbGeAlD
Arsenic trioxide—TXNRD1—central nervous system—schizophrenia	0.001	0.00965	CbGeAlD
Arsenic trioxide—JUN—blood—schizophrenia	0.001	0.00964	CbGeAlD
Arsenic trioxide—AKT1—endocrine gland—schizophrenia	0.000999	0.00961	CbGeAlD
Arsenic trioxide—IKBKB—blood—schizophrenia	0.000998	0.00959	CbGeAlD
Arsenic trioxide—MAPK3—nervous system—schizophrenia	0.000992	0.00953	CbGeAlD
Arsenic trioxide—JUN—midbrain—schizophrenia	0.00099	0.00952	CbGeAlD
Arsenic trioxide—TXNRD1—cerebellum—schizophrenia	0.000981	0.00944	CbGeAlD
Arsenic trioxide—MAPK3—central nervous system—schizophrenia	0.000955	0.00918	CbGeAlD
Arsenic trioxide—AKT1—nervous system—schizophrenia	0.000935	0.00899	CbGeAlD
Arsenic trioxide—MAPK3—cerebellum—schizophrenia	0.000933	0.00897	CbGeAlD
Arsenic trioxide—AKT1—central nervous system—schizophrenia	0.0009	0.00866	CbGeAlD
Arsenic trioxide—AKT1—cerebellum—schizophrenia	0.00088	0.00846	CbGeAlD
Arsenic trioxide—JUN—endocrine gland—schizophrenia	0.00087	0.00836	CbGeAlD
Arsenic trioxide—IKBKB—endocrine gland—schizophrenia	0.000865	0.00832	CbGeAlD
Arsenic trioxide—MAPK1—brain—schizophrenia	0.000856	0.00823	CbGeAlD
Arsenic trioxide—JUN—nervous system—schizophrenia	0.000814	0.00783	CbGeAlD
Arsenic trioxide—IKBKB—nervous system—schizophrenia	0.00081	0.00779	CbGeAlD
Arsenic trioxide—TXNRD1—brain—schizophrenia	0.000797	0.00766	CbGeAlD
Arsenic trioxide—JUN—central nervous system—schizophrenia	0.000784	0.00753	CbGeAlD
Arsenic trioxide—IKBKB—central nervous system—schizophrenia	0.00078	0.0075	CbGeAlD
Arsenic trioxide—JUN—cerebellum—schizophrenia	0.000766	0.00736	CbGeAlD
Arsenic trioxide—IKBKB—cerebellum—schizophrenia	0.000762	0.00733	CbGeAlD
Arsenic trioxide—MAPK3—brain—schizophrenia	0.000758	0.00729	CbGeAlD
Arsenic trioxide—CYP3A4—blood plasma—schizophrenia	0.000757	0.00728	CbGeAlD
Arsenic trioxide—CYP1B1—telencephalon—schizophrenia	0.000735	0.00707	CbGeAlD
Arsenic trioxide—AKT1—brain—schizophrenia	0.000715	0.00687	CbGeAlD
Arsenic trioxide—JUN—brain—schizophrenia	0.000622	0.00598	CbGeAlD
Arsenic trioxide—IKBKB—brain—schizophrenia	0.000619	0.00595	CbGeAlD
Arsenic trioxide—CYP1B1—gonad—schizophrenia	0.000613	0.0059	CbGeAlD
Arsenic trioxide—ABCC2—blood—schizophrenia	0.000546	0.00525	CbGeAlD
Arsenic trioxide—ABCB1—blood plasma—schizophrenia	0.000536	0.00515	CbGeAlD
Arsenic trioxide—CYP1B1—blood—schizophrenia	0.000534	0.00514	CbGeAlD
Arsenic trioxide—ABCC2—endocrine gland—schizophrenia	0.000473	0.00455	CbGeAlD
Arsenic trioxide—CYP1B1—endocrine gland—schizophrenia	0.000464	0.00446	CbGeAlD
Arsenic trioxide—CYP1B1—nervous system—schizophrenia	0.000434	0.00417	CbGeAlD
Arsenic trioxide—CYP1B1—central nervous system—schizophrenia	0.000418	0.00402	CbGeAlD
Arsenic trioxide—CYP1B1—cerebellum—schizophrenia	0.000408	0.00393	CbGeAlD
Arsenic trioxide—CYP1A1—blood—schizophrenia	0.000378	0.00363	CbGeAlD
Arsenic trioxide—CYP1B1—brain—schizophrenia	0.000332	0.00319	CbGeAlD
Arsenic trioxide—CYP1A1—endocrine gland—schizophrenia	0.000328	0.00315	CbGeAlD
Arsenic trioxide—CYP1A1—nervous system—schizophrenia	0.000307	0.00295	CbGeAlD
Arsenic trioxide—CYP1A1—central nervous system—schizophrenia	0.000295	0.00284	CbGeAlD
Arsenic trioxide—ABCB1—forebrain—schizophrenia	0.000293	0.00282	CbGeAlD
Arsenic trioxide—CYP3A4—blood—schizophrenia	0.000277	0.00267	CbGeAlD
Arsenic trioxide—ABCB1—telencephalon—schizophrenia	0.00027	0.00259	CbGeAlD
Arsenic trioxide—CYP3A4—endocrine gland—schizophrenia	0.00024	0.00231	CbGeAlD
Arsenic trioxide—CYP1A1—brain—schizophrenia	0.000234	0.00225	CbGeAlD
Arsenic trioxide—ABCB1—gonad—schizophrenia	0.000225	0.00217	CbGeAlD
Arsenic trioxide—CYP3A4—nervous system—schizophrenia	0.000225	0.00216	CbGeAlD
Arsenic trioxide—CYP3A4—central nervous system—schizophrenia	0.000217	0.00208	CbGeAlD
Arsenic trioxide—ABCB1—blood—schizophrenia	0.000196	0.00189	CbGeAlD
Arsenic trioxide—ABCB1—midbrain—schizophrenia	0.000194	0.00186	CbGeAlD
Arsenic trioxide—ABCB1—endocrine gland—schizophrenia	0.00017	0.00164	CbGeAlD
Arsenic trioxide—ABCB1—nervous system—schizophrenia	0.000159	0.00153	CbGeAlD
Arsenic trioxide—ABCB1—central nervous system—schizophrenia	0.000153	0.00147	CbGeAlD
Arsenic trioxide—ABCB1—cerebellum—schizophrenia	0.00015	0.00144	CbGeAlD
Arsenic trioxide—ABCB1—brain—schizophrenia	0.000122	0.00117	CbGeAlD
Arsenic trioxide—CYP3A4—Metabolism—NDST3—schizophrenia	6.43e-06	2.63e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gene Expression—ESR1—schizophrenia	6.42e-06	2.63e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—DRD2—schizophrenia	6.39e-06	2.61e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—HTR7—schizophrenia	6.39e-06	2.61e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling by NGF—AKT1—schizophrenia	6.38e-06	2.61e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—MTHFR—schizophrenia	6.38e-06	2.61e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GCLM—schizophrenia	6.38e-06	2.61e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—TPH1—schizophrenia	6.38e-06	2.61e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—APOA1—schizophrenia	6.36e-06	2.6e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—S100B—schizophrenia	6.34e-06	2.59e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—PRL—schizophrenia	6.34e-06	2.59e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—EP300—schizophrenia	6.29e-06	2.58e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—GSK3B—schizophrenia	6.28e-06	2.57e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—TNF—schizophrenia	6.27e-06	2.57e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GAPDH—schizophrenia	6.27e-06	2.56e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CNR1—schizophrenia	6.26e-06	2.56e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—FOS—schizophrenia	6.24e-06	2.55e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—APOE—schizophrenia	6.24e-06	2.55e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CLOCK—schizophrenia	6.21e-06	2.54e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—APOE—schizophrenia	6.2e-06	2.54e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—APOA1—schizophrenia	6.17e-06	2.53e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	6.12e-06	2.51e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—DRD2—schizophrenia	6.11e-06	2.5e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—HTR7—schizophrenia	6.11e-06	2.5e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—SLC27A5—schizophrenia	6.1e-06	2.5e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ACSL6—schizophrenia	6.1e-06	2.5e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—S100B—schizophrenia	6.09e-06	2.49e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—TNF—schizophrenia	6.08e-06	2.49e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—ERBB4—schizophrenia	6.06e-06	2.48e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—TPH2—schizophrenia	6.05e-06	2.48e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CACNB2—schizophrenia	6.05e-06	2.48e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—GSK3B—schizophrenia	6.04e-06	2.47e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—PRL—schizophrenia	6.03e-06	2.47e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—EP300—schizophrenia	6.02e-06	2.46e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—FOS—schizophrenia	6e-06	2.45e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PRKD1—schizophrenia	6e-06	2.45e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—COMT—schizophrenia	5.95e-06	2.44e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—DPYD—schizophrenia	5.95e-06	2.44e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—APOE—schizophrenia	5.94e-06	2.43e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—GSTP1—schizophrenia	5.93e-06	2.43e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—MAOA—schizophrenia	5.91e-06	2.42e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—S100B—schizophrenia	5.91e-06	2.42e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—APOA1—schizophrenia	5.87e-06	2.4e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—GSK3B—schizophrenia	5.86e-06	2.4e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—ERBB4—schizophrenia	5.83e-06	2.38e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—DAO—schizophrenia	5.82e-06	2.38e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—FOS—schizophrenia	5.82e-06	2.38e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—MTHFR—schizophrenia	5.79e-06	2.37e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—TNF—schizophrenia	5.79e-06	2.37e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PRL—schizophrenia	5.77e-06	2.36e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism of lipids and lipoproteins—EP300—schizophrenia	5.73e-06	2.35e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—PLA2G4A—schizophrenia	5.7e-06	2.33e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—ERBB4—schizophrenia	5.65e-06	2.31e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—S100B—schizophrenia	5.62e-06	2.3e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—ABCB1—schizophrenia	5.61e-06	2.3e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—NRG1—schizophrenia	5.6e-06	2.29e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—EP300—schizophrenia	5.59e-06	2.29e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PNP—schizophrenia	5.58e-06	2.28e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—GSK3B—schizophrenia	5.57e-06	2.28e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—GSK3B—schizophrenia	5.57e-06	2.28e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—MEF2C—schizophrenia	5.55e-06	2.27e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—FOS—schizophrenia	5.54e-06	2.27e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CACNA1C—schizophrenia	5.54e-06	2.27e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—schizophrenia	5.48e-06	2.24e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—PLA2G4A—schizophrenia	5.48e-06	2.24e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—GSTM1—schizophrenia	5.45e-06	2.23e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—PLA2G4A—schizophrenia	5.45e-06	2.23e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—TP53—schizophrenia	5.42e-06	2.22e-05	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism—AKT1—schizophrenia	5.42e-06	2.22e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—GSK3B—schizophrenia	5.41e-06	2.21e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PIK3C2A—schizophrenia	5.39e-06	2.21e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—APOE—schizophrenia	5.39e-06	2.21e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—S100B—schizophrenia	5.38e-06	2.2e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—NRG1—schizophrenia	5.38e-06	2.2e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—ERBB4—schizophrenia	5.38e-06	2.2e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—YWHAZ—schizophrenia	5.36e-06	2.19e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—GSK3B—schizophrenia	5.33e-06	2.18e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—MEF2C—schizophrenia	5.33e-06	2.18e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—APOA1—schizophrenia	5.33e-06	2.18e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—PLA2G4A—schizophrenia	5.31e-06	2.17e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—FOS—schizophrenia	5.3e-06	2.17e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—TP53—schizophrenia	5.26e-06	2.15e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—ERBB3—schizophrenia	5.24e-06	2.15e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—NRG1—schizophrenia	5.22e-06	2.13e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—NDUFV2—schizophrenia	5.19e-06	2.12e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MEF2C—schizophrenia	5.17e-06	2.12e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—YWHAZ—schizophrenia	5.15e-06	2.11e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—ERBB4—schizophrenia	5.14e-06	2.11e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—GSK3B—schizophrenia	5.14e-06	2.11e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—PLA2G4A—schizophrenia	5.06e-06	2.07e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—HTR2A—schizophrenia	5.05e-06	2.07e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—ERBB3—schizophrenia	5.04e-06	2.06e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GAPDH—schizophrenia	5.01e-06	2.05e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—TP53—schizophrenia	5e-06	2.05e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—YWHAZ—schizophrenia	5e-06	2.04e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cell Cycle—TP53—schizophrenia	4.96e-06	2.03e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—NRG1—schizophrenia	4.96e-06	2.03e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CLOCK—schizophrenia	4.96e-06	2.03e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MEF2C—schizophrenia	4.92e-06	2.01e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—ERBB3—schizophrenia	4.89e-06	2e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PIP4K2A—schizophrenia	4.88e-06	2e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—HTR2A—schizophrenia	4.85e-06	1.98e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CYP2D6—schizophrenia	4.84e-06	1.98e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—SNAP25—schizophrenia	4.84e-06	1.98e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PLA2G4A—schizophrenia	4.84e-06	1.98e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—TPH2—schizophrenia	4.83e-06	1.98e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CACNB2—schizophrenia	4.83e-06	1.98e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	4.83e-06	1.98e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—MTHFR—schizophrenia	4.81e-06	1.97e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—DPYD—schizophrenia	4.76e-06	1.95e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—YWHAZ—schizophrenia	4.75e-06	1.95e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—NRG1—schizophrenia	4.75e-06	1.94e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle—TP53—schizophrenia	4.72e-06	1.93e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MEF2C—schizophrenia	4.7e-06	1.93e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—HTR2A—schizophrenia	4.7e-06	1.92e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—APOE—schizophrenia	4.69e-06	1.92e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—APOA1—schizophrenia	4.65e-06	1.9e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—ERBB3—schizophrenia	4.65e-06	1.9e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—APOA1—schizophrenia	4.64e-06	1.9e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL1B—schizophrenia	4.63e-06	1.89e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—YWHAZ—schizophrenia	4.55e-06	1.86e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—AKT1—schizophrenia	4.53e-06	1.85e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—APOE—schizophrenia	4.51e-06	1.84e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—APOE—schizophrenia	4.48e-06	1.83e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—ESR1—schizophrenia	4.48e-06	1.83e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—HTR2A—schizophrenia	4.47e-06	1.83e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—APOA1—schizophrenia	4.46e-06	1.82e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—ERBB3—schizophrenia	4.45e-06	1.82e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL1B—schizophrenia	4.44e-06	1.82e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—AKT1—schizophrenia	4.44e-06	1.82e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—APOA1—schizophrenia	4.43e-06	1.81e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CACNA1C—schizophrenia	4.42e-06	1.81e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP26B1—schizophrenia	4.41e-06	1.8e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CYP1A2—schizophrenia	4.38e-06	1.79e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—APOE—schizophrenia	4.37e-06	1.79e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—APOA1—schizophrenia	4.32e-06	1.77e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—TH—schizophrenia	4.31e-06	1.76e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL1B—schizophrenia	4.31e-06	1.76e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PIK3C2A—schizophrenia	4.31e-06	1.76e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—AKT1—schizophrenia	4.31e-06	1.76e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—ESR1—schizophrenia	4.3e-06	1.76e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—AKT1—schizophrenia	4.29e-06	1.76e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—HTR2A—schizophrenia	4.28e-06	1.75e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—AKT1—schizophrenia	4.23e-06	1.73e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—ESR1—schizophrenia	4.17e-06	1.71e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—APOE—schizophrenia	4.16e-06	1.7e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—EP300—schizophrenia	4.13e-06	1.69e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—APOA1—schizophrenia	4.11e-06	1.68e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL1B—schizophrenia	4.1e-06	1.68e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	4.08e-06	1.67e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—GSK3B—schizophrenia	4.06e-06	1.66e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—TP53—schizophrenia	4e-06	1.64e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—AKT1—schizophrenia	4e-06	1.64e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—APOE—schizophrenia	3.98e-06	1.63e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—EP300—schizophrenia	3.97e-06	1.63e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—ESR1—schizophrenia	3.97e-06	1.63e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—APOA1—schizophrenia	3.93e-06	1.61e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—TPH1—schizophrenia	3.93e-06	1.61e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GCLM—schizophrenia	3.93e-06	1.61e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL1B—schizophrenia	3.92e-06	1.61e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—GSK3B—schizophrenia	3.9e-06	1.6e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—SNAP25—schizophrenia	3.86e-06	1.58e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CYP2D6—schizophrenia	3.86e-06	1.58e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—EP300—schizophrenia	3.85e-06	1.58e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—AKT1—schizophrenia	3.8e-06	1.56e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—ESR1—schizophrenia	3.8e-06	1.55e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—GSK3B—schizophrenia	3.79e-06	1.55e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PRKD1—schizophrenia	3.69e-06	1.51e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—EP300—schizophrenia	3.67e-06	1.5e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—COMT—schizophrenia	3.67e-06	1.5e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—EP300—schizophrenia	3.67e-06	1.5e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GSTP1—schizophrenia	3.65e-06	1.49e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—MAOA—schizophrenia	3.64e-06	1.49e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—AKT1—schizophrenia	3.64e-06	1.49e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—GSK3B—schizophrenia	3.6e-06	1.47e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—EP300—schizophrenia	3.56e-06	1.46e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—EP300—schizophrenia	3.53e-06	1.44e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—EP300—schizophrenia	3.51e-06	1.44e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CYP1A2—schizophrenia	3.49e-06	1.43e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—AKT1—schizophrenia	3.49e-06	1.43e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—ABCB1—schizophrenia	3.45e-06	1.41e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—GSK3B—schizophrenia	3.45e-06	1.41e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—TH—schizophrenia	3.44e-06	1.41e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—EP300—schizophrenia	3.38e-06	1.39e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—AKT1—schizophrenia	3.38e-06	1.38e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PLA2G4A—schizophrenia	3.35e-06	1.37e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GSTM1—schizophrenia	3.35e-06	1.37e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GAPDH—schizophrenia	3.08e-06	1.26e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—EP300—schizophrenia	3.07e-06	1.26e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CLOCK—schizophrenia	3.06e-06	1.25e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—TPH2—schizophrenia	2.98e-06	1.22e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CACNB2—schizophrenia	2.98e-06	1.22e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—MTHFR—schizophrenia	2.96e-06	1.21e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—DPYD—schizophrenia	2.93e-06	1.2e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—COMT—schizophrenia	2.93e-06	1.2e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GSTP1—schizophrenia	2.91e-06	1.19e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—MAOA—schizophrenia	2.91e-06	1.19e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—APOE—schizophrenia	2.76e-06	1.13e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—APOA1—schizophrenia	2.73e-06	1.12e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CACNA1C—schizophrenia	2.72e-06	1.11e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PLA2G4A—schizophrenia	2.68e-06	1.1e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GSTM1—schizophrenia	2.68e-06	1.1e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—EP300—schizophrenia	2.67e-06	1.09e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PIK3C2A—schizophrenia	2.65e-06	1.09e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—EP300—schizophrenia	2.57e-06	1.05e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—EP300—schizophrenia	2.55e-06	1.04e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—AKT1—schizophrenia	2.55e-06	1.04e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—AKT1—schizophrenia	2.5e-06	1.02e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—EP300—schizophrenia	2.49e-06	1.02e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—AKT1—schizophrenia	2.42e-06	9.92e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—SNAP25—schizophrenia	2.38e-06	9.74e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP2D6—schizophrenia	2.38e-06	9.74e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—EP300—schizophrenia	2.37e-06	9.7e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—MTHFR—schizophrenia	2.37e-06	9.69e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—AKT1—schizophrenia	2.33e-06	9.53e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gene Expression—AKT1—schizophrenia	2.32e-06	9.48e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—EP300—schizophrenia	2.27e-06	9.28e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—AKT1—schizophrenia	2.22e-06	9.07e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—APOE—schizophrenia	2.2e-06	9.02e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—APOA1—schizophrenia	2.18e-06	8.92e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP1A2—schizophrenia	2.15e-06	8.81e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—AKT1—schizophrenia	2.15e-06	8.8e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—TH—schizophrenia	2.12e-06	8.68e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—AKT1—schizophrenia	2.12e-06	8.67e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—AKT1—schizophrenia	2.05e-06	8.37e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TP53—schizophrenia	1.91e-06	7.83e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TP53—schizophrenia	1.84e-06	7.52e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—COMT—schizophrenia	1.8e-06	7.38e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GSTP1—schizophrenia	1.8e-06	7.35e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—MAOA—schizophrenia	1.79e-06	7.33e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TP53—schizophrenia	1.78e-06	7.3e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ABCB1—schizophrenia	1.7e-06	6.96e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TP53—schizophrenia	1.7e-06	6.94e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GSTM1—schizophrenia	1.65e-06	6.75e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PLA2G4A—schizophrenia	1.65e-06	6.75e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TP53—schizophrenia	1.62e-06	6.64e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—AKT1—schizophrenia	1.62e-06	6.61e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—EP300—schizophrenia	1.57e-06	6.44e-06	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—AKT1—schizophrenia	1.54e-06	6.31e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—AKT1—schizophrenia	1.51e-06	6.16e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—MTHFR—schizophrenia	1.46e-06	5.97e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—AKT1—schizophrenia	1.43e-06	5.86e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—AKT1—schizophrenia	1.37e-06	5.61e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—APOE—schizophrenia	1.36e-06	5.56e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—APOA1—schizophrenia	1.34e-06	5.49e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—EP300—schizophrenia	1.26e-06	5.14e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—AKT1—schizophrenia	9.5e-07	3.89e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—EP300—schizophrenia	7.74e-07	3.17e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—AKT1—schizophrenia	7.59e-07	3.11e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—AKT1—schizophrenia	4.68e-07	1.91e-06	CbGpPWpGaD
